本页面由Tiger Trade Technology Pte. Ltd.提供服务

Fate Therapeutics Inc

1.09
-0.0300-2.68%
成交量:162.30万
成交额:182.37万
市值:1.26亿
市盈率:-0.83
高:1.19
开:1.12
低:1.08
收:1.12
52周最高:2.02
52周最低:0.6611
股本:1.15亿
流通股本:1.01亿
量比:1.38
换手率:1.61%
股息:- -
股息率:- -
每股收益(TTM):-1.3180
每股收益(LYR):-1.6384
净资产收益率:-52.35%
总资产收益率:-23.85%
市净率:0.54
市盈率(LYR):-0.67

数据加载中...

2024/03/25

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/25

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/29

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

SEC问询函

Form CORRESP - Correspondence
2023/11/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

重要事件披露

Form 8-K - Current report